8-OH-DPAT
8-OH-DPAT
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin) is a research chemical that acts as a selective agonist of the 5-HT1A receptor, a subtype of the serotonin receptor. It is commonly used in scientific research to study the role of the 5-HT1A receptor in various physiological and behavioral processes.
Pharmacology
8-OH-DPAT is known for its high affinity and selectivity for the 5-HT1A receptor, which is a G protein-coupled receptor (GPCR) involved in the modulation of serotonin levels in the brain. Activation of this receptor by 8-OH-DPAT can lead to various effects, including changes in mood, anxiety, and thermoregulation.
Mechanism of Action
8-OH-DPAT binds to the 5-HT1A receptor, which is primarily located in the central nervous system (CNS). Upon binding, it activates the receptor, leading to the inhibition of adenylate cyclase activity and a decrease in the production of cyclic AMP (cAMP). This results in the modulation of neurotransmitter release and neuronal excitability.
Uses in Research
8-OH-DPAT is widely used in neuroscience research to investigate the role of the 5-HT1A receptor in various conditions, such as depression, anxiety disorders, and schizophrenia. It is also used to study the effects of serotonin on thermoregulation and sexual behavior in animal models.
Behavioral Studies
In behavioral studies, 8-OH-DPAT is often used to assess its anxiolytic and antidepressant-like effects. It has been shown to reduce anxiety-like behavior in the elevated plus maze and open field test in rodents.
Physiological Studies
8-OH-DPAT is also used to study its effects on body temperature regulation. It has been observed to induce hypothermia in rodents, which is thought to be mediated by its action on the 5-HT1A receptor.
Related Compounds
8-OH-DPAT is part of a class of compounds known as serotonin receptor agonists. Other related compounds include buspirone, tandospirone, and flesinoxan, which also target the 5-HT1A receptor but may have different selectivity and efficacy profiles.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD